Executive Advisor and Board professional with over 30 years’ experience in Senior Leadership roles including CEO, CFO and Corporate Relations in the Life Science, Telecommunications and Automotive industries.
I have navigated both publicly listed and privately owned companies through complex and challenging situations, with positive outcomes. I am passionate about driving sustainable change through strategic management, business development, communication and internal engagement and can support companies at various stages of maturity in leading with more confidence, influence and impact while scaling up their business.
BioArctic develops innovative drugs that improve the lives of patients with disorders of the central nervous system and have the potential to revolutionize the treatment of disorders such as Alzheimer’s disease, Parkinson’s disease, and ALS, as well as advanced technology to facilitate the passage of drugs across the blood-brain barrier.
Flerie Invest is a Nordic evergreen life science investment firm that builds pioneering companies and advance their pipeline to make a positive impact on health and well-being.
Neonode transforms the way humans and machines interact by specializing in optical sensing technologies that enable touchless interaction, object detection, infrared touch and scene analysis via machine perception.
I provide advisory services in strategic management, business development, communication, finance and sustainability and also act as an interim manager, currently as acting CFO at A3P Biomedical AB, where we completed a private placement of SEK 400 million in May 2022.
A3P Biomedical’s mission is to improve quality of life of men by radically increasing the precision in prostate cancer diagnostics. The company’s lead product Stockholm3 is a blood test for early detection of aggressive prostate cancer.